Blog Detail

For decades, ADHD research and diagnostic criteria were built largely around how the condition shows up in young boys — visibly hyperactive, disruptive, easy to spot in a classroom. That’s a big part of why so many women reach adulthood, sometimes well into their thirties or forties, before anyone — including them — seriously considers ADHD. Understanding why requires looking past stereotypes most people, including many clinicians, were trained on.

A different, quieter presentation

ADHD in women more often presents as the inattentive type rather than the hyperactive-impulsive type — daydreaming, losing focus, feeling mentally scattered or “foggy,” rather than visibly bouncing off the walls. Internally, there’s often just as much restlessness, but it’s experienced as racing thoughts or internal fidgeting rather than outward physical hyperactivity. Because this presentation is quieter and less disruptive to other people, it’s far less likely to prompt a teacher, parent or GP to suggest an assessment — even though the day-to-day impact on the person themselves can be just as significant.

Misdiagnosis as anxiety or depression

Many women with undiagnosed ADHD are instead diagnosed, often repeatedly, with anxiety or depression — and the overlap is real, because living for years with unrecognised ADHD genuinely does produce anxiety and low mood. The difficulty is that treating the anxiety or depression alone, without addressing the ADHD underneath it, tends to produce partial or short-lived improvement, because the root driver — the attention and executive function difficulties — is still there. This is one of the more common reasons people describe years of therapy or medication for mood that never quite “worked,” followed by relief once ADHD is identified and addressed directly.

Masking and the cost of coping well

Many women with ADHD become highly skilled at masking — building elaborate compensatory systems, working far harder than peers to hit the same outcomes, and presenting as capable and organised while privately exhausted. Hormonal fluctuation adds another layer: many women report their ADHD symptoms becoming markedly harder to manage around their menstrual cycle, during perimenopause, or postpartum, as oestrogen (which interacts with dopamine regulation) fluctuates — a pattern clinicians are increasingly aware of, though it isn’t yet consistently assessed for.

What this means for diagnosis and support

None of this means women’s ADHD is harder to treat — it means it’s harder to recognise, which delays support that can genuinely help far sooner than it typically arrives. If you’ve been treated for anxiety or depression for years without lasting improvement, or if you recognise the masking pattern described above, it’s worth specifically asking whether ADHD has ever been considered — not just raising mood symptoms again. A screening questionnaire is a reasonable, low-friction way to find out whether it’s worth pursuing further, whatever route you take next.

Our free screening takes a few minutes and gives you a plain-English starting point, regardless of how long you’ve been carrying this.